ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.
Sandra Angèle(Centre international de recherche sur le cancer), Janet Hall(Centre international de recherche sur le cancer), Paola Pisani(Centre International de Recherche sur le Cancer), David G. Cox(Université Claude Bernard Lyon 1), Norman Moullan(Nestlé (Switzerland)), Wim Jongmans(Radboud University Nijmegen), Brigitte Chapot(Centre international de recherche sur le cancer), Jean Pierre Gérard(Hospices Civils de Lyon), Marlin D. Friesen(Johns Hopkins University), M Vuillaume(Centre international de recherche sur le cancer), P. Romestaing(Hospices Civils de Lyon)
PubMed
December 15, 2003
Cited by 210
Related Papers
Global Cancer Statistics, 2002
|CA A Cancer Journal for Clinicians|2005|18.4k
Estimating the world cancer burden: Globocan 2000
|International Journal of Cancer|2001|3.7k
Global cancer statistics
|CA A Cancer Journal for Clinicians|1999|3.4k
Estimates of the worldwide incidence of 25 major cancers in 1990
|International Journal of Cancer|1999|2.1k
Estimates of the worldwide incidence of eighteen major cancers in 1985
|International Journal of Cancer|1993|1.7k